Amanda Emmons

Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors

Emmanuel H. Demont, Chun‐wa Chung, Rebecca C. Furze, Paola Grandi et autres

gb, de (code pays fourni par la source)

Corrigendum to “In vivo activity of an azole series of CCR2 antagonists” [Bioorg. Med. Chem. Lett. 22 (2012) 7252–7255]

Chris A. Smethurst, Nicola Bevan, Carl Brooks, Amanda Emmons et autres

gb, us (code pays fourni par la source)

In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison, R G Sturton et autres

gb (code pays fourni par la source)

Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans

Andrew W. Harrell, Sarah Siederer, Jo Bal, Nainesh H. Patel et autres

gb (code pays fourni par la source)

In vivo activity of an azole series of CCR2 antagonists

Chris A. Smethurst, Nicola Bevan, Carl Brooks, Amanda Emmons et autres

gb, us (code pays fourni par la source)

CCR2 receptor antagonists: Optimization of biaryl sulfonamides to increase activity in whole blood

Gren Z. Wang, Pamela A. Haile, Tom Daniel, Benjamin Belot et autres

us (code pays fourni par la source)

The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings

Panayiotis A. Procopiou, Victoria J. Barrett, Nicola Bevan, Peter R. Butchers et autres

gb (code pays fourni par la source)

The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists

Gillian E. Lunniss, Ashley Barnes, Nick Barton, Matteo Biagetti et autres

gb, it (code pays fourni par la source)

Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach

Panayiotis A. Procopiou, Victoria J. Barrett, Nicola Bevan, Keith Biggadike et autres

gb, au (code pays fourni par la source)

In Vitro Pharmacological Characterisation Of GW642444, A Novel Long Acting ²2-agonist (LABA) Using Human Recombinant ²1/2/3 Adrenoceptor CAMP Assays

Victoria J. Barrett, Amanda Emmons, Alison J. Ford, Richard Knowles

The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists

Gillian E. Lunniss, Ashley Barnes, Nick Barton, Matteo Biagetti et autres

gb, it (code pays fourni par la source)

Development of an insect-cell-based assay for detection of kinase inhibition using NF-κB-inducing kinase as a paradigm

Namir J. Hassan, Sheraz Gul, Fiona Flett, Edward Hollingsworth et autres

gb (code pays fourni par la source)